Goldstraw, P., Crowley, J., Chansky, K., Giroux, D.J., Groome, P.A., Rami-Porta, R., Postmus, P.E., Rusch, V. and Sobin, L. (2007) International Association for the Study of Lung Cancer International Staging Committee, Participating Institutions. The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours. Journal of Thoracic Oncology, 2, 706-714.
http://dx.doi.org/10.1097/JTO.0b013e31812f3c1a
TITLE: Outcomes of Quality of Life Regarding the Next-Generation Thoracoscopic Intrapleural Hyperthermic Chemotherapy of Non-Small Cell Lung Cancer with Dissemination
AUTHORS: Takanori Ayabe, Masaki Tomita, Eiichi Chosa, Kosuke Mori, Kunihide Nakamura
KEYWORDS: Non-Small Cell Lung Cancer, Intrapleural, Hyperthermic, Chemotherapy, Cisplatin, S-1, Quality of Life
JOURNAL NAME: Journal of Cancer Therapy, Vol.7 No.1, January 28, 2016
ABSTRACT: Background: We have developed a new next-generation intrapleural hyperthermic chemotherapy (IPHC) for non-small cell lung cancer with dissemination, which is a hybrid chemotherapy combined with oral S-1 medication plus conventional cisplatin-based IPHC. We now report the preliminary feasibility and outcome of quality of life (QOL) regarding this hybrid IPHC. Methods: The patient was a 76-year-old male with a 2-cm nodule in the left upper lobe. After partial resection by video-assisted thoracic surgery (VATS), which was diagnosed with advanced pulmonary adenocarcinoma with intrapleural dissemination. We initially performed two regimens of systemic chemotherapy, S-1 (day 1 - 21, 100 mg 2X/day) + CDDP (day 8, 60 mg/m2) and S-1 (day 1 - 14,100 mg 2X/day) + CBDCA (day 1, AUC 5). The regimen of next-generation IPHC is oral S-1 medication (day 1 - 21, 100 mg/day) + intrapleural hyperthermic perfusion of cisplatin (200 mg/m2) with VATS (day 8,43°C, 2 hours). Adverse outcomes, QOL, and pleural effusion were assessed in three regimens. To investigate the outcomes of the QOL, the European Organization for Research and Treatment of Cancer QOL Questionnaire (EORTC QLQ-C30 and QLQ-LC13), the QOL questionnaire for cancer patients treated with anticancer drugs (QOL-ACD), the Cancer Dyspnea Score (CDS), and the St. George's Respiratory Questionnaire (SGRQ) were used. Results: During the IPHC treatment course, grade 3 neutropenia, anemia, and diarrhea were observed. The physical function after IPHC became worse compared to that before the IPHC. Fatigue during chemotherapy (CBDCA+S-1) was more pronounced than that during the IPHC. Nausea, vomiting, and diarrhea during the IPHC were prevalent than those of chemotherapy. The overall QOL after the IPHC was improved compared to that before the IPHC. Regarding before and after the IPHC, the physical function after the IPHC became worse compared to that before the IPHC, on the other hand, the global QOL before and after the IPHC had not dramatically changed. Pleural effusion was controlled after the IPHC for more than 1 year. Conclusion: The first case of a clinical trial of the next-generation IPHC showed grade 3 adverse events. However, it was an acceptable feasibility compared to the usual platinum doublet chemotherapy. The effectiveness of the IPHC allowed the patient to obtain a good control of the pleural effusion and preserved the patient's QOL.
Multiple Detector-Row CT in Gastric Cancer Staging: Prospective Study
Lorenzo Bruno, Lucia Barni, Gaia Masini, Sabrina Pacciani, Edvige Lucarelli, Antonella Masserelli, Daniela Tomcykova, Filippo Melli, Luca Boni, Giancarlo Freschi, Paolo Bechi
DOI: 10.4236/jct.2014.514145 3,328 Downloads 3,992 Views Citations
18FDG-PET/CT Is a Useful Tool in Staging Procedure before Chemo-Radiotherapy in Patients with Limited Disease Small-Cell Lung Cancer. Pattern of Failure and Survival Is Analyzed
Anne Winther Larsen, Azza A. Khalil, Peter Meldgaard, Marianne M. Knap
Pub. Date: September 12, 2012
Endoscopic Staging and Treatment of Early Gastric Cancer
Angel Ferrández, Sonia Mostacero, Angel Lanas
DOI: 10.4236/jct.2013.41A013 6,437 Downloads 9,224 Views Citations
A Study on Lung Cancer in Jianghan Plain
Kun Zhang, Man Li, Yanhua Zhang, Xiaochun Peng
DOI: 10.4236/health.2014.612164 3,620 Downloads 4,286 Views Citations
Pub. Date: June 9, 2014
Assessment of Diagnostic Accuracy of Bronchoalveolar Lavage Cytology in the Diagnosis of Lung Tumors and Contribution to the Classification of Non-Small Cell Lung Cancer Entities: A Retrospective Clinocopathological Study
Annette Zimpfer, Antonia Polak, Andrea Bier, Guenther Kundt, Jana Kölbel, Friedrich Prall, Johann C. Virchow, Andreas Erbersdobler
DOI: 10.4236/ojpathology.2013.33019 4,094 Downloads 6,522 Views Citations
Pub. Date: June 28, 2013